• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌筛查:分子粪便分析的前景

Colorectal cancer screening: prospects for molecular stool analysis.

作者信息

Davies R Justin, Miller Richard, Coleman Nicholas

机构信息

Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge, CB2 2XZ, UK.

出版信息

Nat Rev Cancer. 2005 Mar;5(3):199-209. doi: 10.1038/nrc1569.

DOI:10.1038/nrc1569
PMID:15738983
Abstract

Colorectal cancer is common. As many patients present with advanced disease, an effective screening test would have substantial clinical benefits. Recent progress in understanding the biology of colorectal cancer (and of cancer cells in general) has led to possible new approaches to screening. In particular, there are prospects of developing tests based on analysis of stool, which promise improved accuracy, safety, affordability and patient compliance.

摘要

结直肠癌很常见。由于许多患者就诊时已处于疾病晚期,一种有效的筛查测试将具有重大的临床益处。最近在理解结直肠癌(以及一般癌细胞)生物学方面取得的进展,带来了可能的新筛查方法。特别是,基于粪便分析开发测试具有前景,有望提高准确性、安全性、可承受性和患者依从性。

相似文献

1
Colorectal cancer screening: prospects for molecular stool analysis.结直肠癌筛查:分子粪便分析的前景
Nat Rev Cancer. 2005 Mar;5(3):199-209. doi: 10.1038/nrc1569.
2
The stool DNA test: an emerging technology in colorectal cancer screening.
Gastroenterol Nurs. 2005 Jan-Feb;28(1):28-32. doi: 10.1097/00001610-200501000-00007.
3
Molecular stool screening for colorectal cancer. Using DNA markers may be beneficial, but large scale evaluation is needed.用于结直肠癌的分子粪便筛查。使用DNA标志物可能有益,但需要大规模评估。
BMJ. 2000 Jul 29;321(7256):254-5. doi: 10.1136/bmj.321.7256.254.
4
Stool screening for colorectal cancer: molecular approaches.结直肠癌的粪便筛查:分子方法
Gastroenterology. 2005 Jan;128(1):192-206. doi: 10.1053/j.gastro.2004.10.041.
5
Stool test for colorectal cancer screening: what is going on?用于结直肠癌筛查的粪便检测:现状如何?
Surg Oncol. 2007 Dec;16 Suppl 1:S43-5. doi: 10.1016/j.suronc.2007.10.034.
6
Molecular detection of colorectal neoplasia.结直肠肿瘤的分子检测。
Gastroenterology. 2010 Jun;138(6):2127-39. doi: 10.1053/j.gastro.2010.01.055.
7
Multi-Target Stool DNA Test: Is the Future Here?多靶点粪便DNA检测:未来已来?
Curr Gastroenterol Rep. 2016 Jun;18(6):30. doi: 10.1007/s11894-016-0510-4.
8
Stool-based DNA tests for colorectal cancer: clinical potential and early results.用于结直肠癌的粪便DNA检测:临床潜力与早期结果
Rev Gastroenterol Disord. 2002;2 Suppl 1:S20-6.
9
Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.粪便 DNA 筛查结直肠肿瘤:高检测率的生物学和技术基础。
Pathology. 2012 Feb;44(2):80-8. doi: 10.1097/PAT.0b013e3283502fdf.
10
Detecting colorectal cancer in stool with the use of multiple genetic targets.利用多种基因靶点在粪便中检测结直肠癌。
J Natl Cancer Inst. 2001 Jun 6;93(11):858-65. doi: 10.1093/jnci/93.11.858.

引用本文的文献

1
A simplified and efficient extracellular vesicle-based proteomics strategy for early diagnosis of colorectal cancer.一种用于结直肠癌早期诊断的简化且高效的基于细胞外囊泡的蛋白质组学策略。
Chem Sci. 2024 Oct 15;15(44):18419-30. doi: 10.1039/d4sc05518g.
2
Landscape of Innovative Methods for Early Diagnosis of Gastric Cancer: A Systematic Review.胃癌早期诊断创新方法的全景:一项系统综述
Diagnostics (Basel). 2023 Dec 5;13(24):3608. doi: 10.3390/diagnostics13243608.
3
Warning Signs From the Crypt: Aberrant Protein Glycosylation Marks Opportunities for Early Colorectal Cancer Detection.
来自 crypt 的警告信号:异常蛋白质糖基化标记为早期结直肠癌检测提供了机会。
Clin Transl Gastroenterol. 2023 Jul 1;14(7):e00592. doi: 10.14309/ctg.0000000000000592.
4
Impact of Reducing Intake of Red and Processed Meat on Colorectal Cancer Incidence in Germany 2020 to 2050-A Simulation Study.2020 至 2050 年德国减少红肉类和加工肉类摄入量对结直肠癌发病率的影响:一项模拟研究。
Nutrients. 2023 Feb 17;15(4):1020. doi: 10.3390/nu15041020.
5
Cell-cell interactions that drive tumorigenesis in .细胞间相互作用驱动 中的肿瘤发生。
Fly (Austin). 2022 Dec;16(1):367-381. doi: 10.1080/19336934.2022.2148828.
6
Cytotoxicity Evaluation of Plastoquinone Analogues against Colorectal and Breast Cancers along with Insights.质体醌类似物对结直肠癌和乳腺癌的细胞毒性评估及相关见解
Pharmaceuticals (Basel). 2022 Oct 14;15(10):1266. doi: 10.3390/ph15101266.
7
Chromatin Dynamics in Digestive System Cancer: Commander and Regulator.消化系统癌症中的染色质动力学:指挥官与调节者
Front Oncol. 2022 Jul 29;12:935877. doi: 10.3389/fonc.2022.935877. eCollection 2022.
8
Aurora kinase A inhibition induces synthetic lethality in SMAD4-deficient colorectal cancer cells via spindle assembly checkpoint activation.极光激酶 A 抑制通过纺锤体组装检查点的激活诱导 SMAD4 缺陷型结直肠癌细胞发生合成致死。
Oncogene. 2022 May;41(19):2734-2748. doi: 10.1038/s41388-022-02293-y. Epub 2022 Apr 7.
9
Is the nuclear factor kappa-b (NF-κB) pathway and inflammatory status associated with colorectal cancer?核因子-κB(NF-κB)通路和炎症状态与结直肠癌有关吗?
Saudi J Gastroenterol. 2022 Jan-Feb;28(1):60-66. doi: 10.4103/sjg.sjg_44_21.
10
Nomogram model characterized by mutant genes and clinical indexes to identify high-risk patients with stage III/IV colorectal cancer.以突变基因和临床指标为特征的列线图模型,用于识别III/IV期结直肠癌高危患者。
J Gastrointest Oncol. 2020 Dec;11(6):1214-1223. doi: 10.21037/jgo-20-548.